SEQIRUS INC - THE PURPOSE OF THIS REQUIREMENT IS TO 1) PROVIDE MEDICAL COUNTERMEASURES (MCMS), SUCH AS VACCINES AND ADJUVANTS, FOR PANDEMIC PREPAREDNESS AND RESPONSE OR AS REQUIRED IN RESPONSE TO A HHS DESIGNATED PUBLIC HEALTH EMERGENCY. 2) PRODUCE VACCINES AG
Key Details
Description
THE PURPOSE OF THIS REQUIREMENT IS TO 1) PROVIDE MEDICAL COUNTERMEASURES (MCMS), SUCH AS VACCINES AND ADJUVANTS, FOR PANDEMIC PREPAREDNESS AND RESPONSE OR AS REQUIRED IN RESPONSE TO A HHS DESIGNATED PUBLIC HEALTH EMERGENCY. 2) PRODUCE VACCINES AG
Context & Analysis
On Dec 12, 2025, Department of Health and Human Services to SEQIRUS INC for the purpose of this requirement is to 1) provide medical countermeasures (mcms), such as vaccines and adjuvants, for pandemic preparedness and response or as required in response to a hhs designated …. The award is classified under NAICS 325414 — BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING and issued as a firm fixed price contract. Competition extent: full and open competition with 4 offers received. The procurement used a NO SET ASIDE USED. set-aside. This award is one of several similar procurements from Department of Health and Human Services under NAICS 325414 — related awards are listed below.
Contractor Information
Similar Awards
DEVELOPMENT AND DOMESTIC MANUFACTURE OF ADJUVANTED, PANDEMIC INFLUENZA VACCINES
SANOFI VACCINES US INC.
$612.2M
OTHER TRANSACTION: PRODUCTION OF DRUG SUBSTANCES AND DRUG PRODUCTS AT COMMERCIAL SCALE UNDER BIOMAP-CONSORTIUM
ADVANCED TECHNOLOGY INTERNATIONAL
$304.0M
EXPANSION OF PRODUCTION CAPACITY OF MAN-MADE FABRIC FOR MANUFACTURING DISPOSABLE MEDICAL GOWNS
ADVANCED TECHNOLOGY INTERNATIONAL
$248.5M
OTHER TRANSACTION: PROCUREMENT AND SUSTAINMENT OF N95 MASK MANUFACTURING CAPACITY UNDER THE BIOMAP-CONSORTIUM.
ADVANCED TECHNOLOGY INTERNATIONAL
$141.3M
EXPANSION OF DOMESTIC MANUFACTURING CAPACITY FOR NITRILE GLOVES
ADVANCED TECHNOLOGY INTERNATIONAL
$61.0M
Stay Updated
Get notified about new opportunities matching your interests.